Navigation Links
Sanofi Oncology and Colon Cancer Coalition Join Forces to Raise Awareness of Colorectal Cancer
Date:3/6/2013

dge area alone.

"At Sanofi Oncology, our mission goes beyond developing innovative medicines and ensuring their availability," said Debasish Roychowdhury , M.D., Senior Vice President and Head, Sanofi Oncology. "Through initiatives like today's proclamation ceremony, we're educating patients and the public about various cancers, prevention, and treatments, to ultimately promote a healthy way of life in the Cambridge community."

About Colorectal Cancer

In 2010, 142,570 new cases were diagnosed and 51,370 people died from colorectal cancer in the United States. When colorectal cancer is diagnosed at an early stage, the five-year survival rate is nearly 90 percent. However, when the cancer is not diagnosed until a late state, the five-year survival rate is closer to 10 percent. In the past ten years, colon cancer screening rates have increased, but rates still remain low, especially among the uninsured. According to the American Cancer Society, men and women should begin screening for colon cancer at age 50. If the entire population was screened at that age, the number of colorectal cancer-related deaths would be cut in half.

About the Colon Cancer Coalition /Get Your Rear in Gear

Get Your Rear in Gear® events are presented nationally by the Colon Cancer Coalition, a non-profit organization based in Minneapolis. The events are 100% volunteer-driven in communities throughout the United States. The Colon Cancer Coalition distributes funds raised at Get Your Rear in Gear events back into local communities for colon cancer education, prevention, and screening. By making the words colon, colorectal and colonoscopy a part of the everyday language, we believe we can overcome the fear and decrease deaths from this largely preventable cancer.
'/>"/>

SOURCE Sanofi
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. PharmaVentures Client Sanofi Wins Scrip Outsourcing Deal of the Year Award
2. Former Sanofi-aventis and US Oncology Executive Joins New Century Health as Chief Executive Officer
3. Sanofi and Regeneron Announce Publication of Positive Phase 2 Results for Lipid-Lowering PCSK9 Antibody in The Lancet
4. Collaboration between Sanofi and Joslin Diabetes Center to focus on new drugs for diabetes
5. Sanofi Signs Agreement for Type 1 Diabetes Research with Boston Academic Teaching Hospital
6. Sanofi and Regeneron Launch Comprehensive Phase 3 Clinical Program With LDL Cholesterol-Lowering PCSK9 Antibody
7. A Look Inside, Factors of Health - Research Report on Novogen Limited, Sanofi SA, ISIS Pharmaceuticals, Inc., Amgen, Inc. and Gilead Sciences, Inc.
8. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
9. OvaGene Oncology Collaborates With Moffitt Cancer Center to Develop and Commercialize microRNAs Associated With Chemotherapeutic Drug Response
10. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
11. Champions Oncology Inc. Receives Approval from U.S. Regulatory Authorities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 2013 Grace Century , an ... life science and health related private equity projects, has ... International Project Team. Dergham's expertise in finance and international ... to Grace Century as it continues to look at ... Dergham holds both an under graduate degree from the ...
(Date:5/20/2013)... ANGELES , May 20, 2013 Today, ... San Francisco , James McGough ... Clinical Psychiatry at the Semel Institute for Neuroscience and ... of Medicine at the University of California Los ... both Child and Adolescent Psychopharmacology and ADHD at UCLA, ...
(Date:5/20/2013)... 20, 2013 Pacific Biomarkers and Clinigene International are ... of biosimilars at the 2013 AAPS/ National Biotechnology ... Hotel and Marina , ... opportunity to speak with company representatives at their collaborative ... on May 21 from 1-2 p.m. in the conference,s ...
(Date:5/20/2013)... CHAPEL HILL, N.C. , May 20, 2013 ... pharmaceutical company focused on developing differentiated antibiotics to ... bacterial infections, today announced that it presented data ... 2013) in Philadelphia demonstrating ... versus levofloxacin in Cempra,s prior Phase 2 clinical ...
Breaking Biology Technology:Dalia Dergham Joins Grace Century FZ LLC International Project Team 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5Pacific Biomarkers and Clinigene International To Announce Laboratory Solutions for Developers of Biosimilars at 2013 AAPS/ National Biotechnology Conference 2Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP) 2
... made clear this week -- with a one-two punch of ... -- that it intends to grow its GE Medical ... actually induce the Fairfield, Conn.-based giant to make additional acquisitions ... the product categories it just bought into, according to a ...
... conditions provide a golden opportunity to tune your talent ... to have calmed, the long-term winners will be those ... strategies. Real competitive advantage comes from making a ... aligning your talent management practice to that choice, even ...
... are still going on in the Midwest at places like the ... news story on Monday. There are many experts giving opinions about ... many jobs are going overseas for cheaper wages and most stop ... to stop because many companies are so focused on the bottom ...
Cached Biology Technology:GE Medicals Acquisitions May Prompt More Purchases 2GE Medicals Acquisitions May Prompt More Purchases 3Talent Constellations or Talent Communities Choosing the Right Talent 2Talent Constellations or Talent Communities Choosing the Right Talent 3Spend Money to Make Money and Dump Obsolete Tech Strategies 2Spend Money to Make Money and Dump Obsolete Tech Strategies 3Spend Money to Make Money and Dump Obsolete Tech Strategies 4
(Date:5/18/2013)... Research presented at Digestive Disease Week (DDW) ... diet and lifestyle. , Individuals suffering from ... strength, fatigue and poor quality of life. These ... remission. A randomized, double blind, placebo-controlled study found ... corresponded to significant relief of these symptoms. ...
(Date:5/17/2013)... The AGA Research Foundation announced a new grant that ... gut microbiota, one of today,s most exciting areas of ... AGA Research Awards Panel selected Andrew T. Chan, MD, ... Harvard Medical School, Boston, as the 2013 AGA-Elsevier Gut ... $25,000 of funding, commencing in July 2013, to test ...
(Date:5/17/2013)... Researchers at Rutgers, The State University of New Jersey, ... proprietary new formulation called Visikol TM that effectively ... be used in place of chloral hydrate, which is ... but which is tightly regulated by the Drug Enforcement ... , Clearing solutions, or clearing agents, are vital for ...
Breaking Biology News(10 mins):Research examines new methods for managing digestive health 2Research examines new methods for managing digestive health 3New gut microbiome research to explore red meat -- colorectal cancer pathway 2New formula invented for microscope viewing, substitutes for federally controlled drug 2New formula invented for microscope viewing, substitutes for federally controlled drug 3
... unpleasant. Nearly 30% of all patients suffer from nausea ... are longer patient stays in the recovery room, with ... prevent postoperative nausea and vomiting. In a systematic review ... treatment recommendations for nausea after general anesthesia can be ...
... Spanish . A common roadside plant could ... biofuel, according to U.S. Department of Agriculture (USDA) studies. ... intramural scientific research agency, have found that field pennycress yields ... in biodiesel production. Field pennycress belongs to the ...
... the Arctic warms, a new cache of resourcessnow goose eggsmay ... In a new study published in an early online edition ... that even large numbers of hungry bears repeatedly raiding nests ... of the geese because of a mismatch in the timing ...
Cached Biology News:Pennycress could go from nuisance weed to new source of biofuel 2Polar bears can't eat geese into extinction 2
MOUSE ANTI RAT RT1Bu / MOUSE Ia:BIOTIN Immunogen: Rat thymocyte membrane glycoproteins...
Prepared in 0.85% saline....
... cloning of BAC (100+kb), fosmid (40kb), and ... stability than any othe BAC vector. On ... yields and easy recombinant DNA purification. Available ... (pSMART VC) vectors for the highest insert ...
Anti-Goat HRP-DAB Cell & Tissue Staining Kit...
Biology Products: